Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares

v3.22.1
Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Schedule of anti dilutive common shares [Abstract]    
Options 2,691,000 1,630,000
Warrants 11,153,908 8,628,908
Convertible debt [1] 100,361
Total potentially dilutive shares 13,844,908 10,359,269
[1] Represents shares issuable upon conversion of debt at various conversion prices, some of which were calculated using the fair value of the Company’s common stock at the respective balance sheet date.